Human papillomavirus (HPV) vaccination coverage in young Australian women is higher than previously estimated: Independent estimates from a nationally representative mobile phone survey

Vaccine

Volumn 32, Issue 5, 2014, Pages 592-597

  Brotherton, Julia M L ^a,b,c   Liu, Bette ^d   Donovan, Basil ^d,e   Kaldor, John M ^d   Saville, Marion ^a  

^a National HPV Vaccination Program Register   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e SYDNEY EYE HOSPITAL   (Australia)

Author keywords

Australia; Human papillomavirus (HPV); Vaccination coverage

Indexed keywords

ADULT; AGE; ARTICLE; AUSTRALIA; CONTROLLED STUDY; FEMALE; GENERAL PRACTICE; HEALTH SURVEY; HUMAN; HUMAN PAPILLOMAVIRUS VACCINATION; INFORMED CONSENT; MAJOR CLINICAL STUDY; MOBILE PHONE; POPULATION RESEARCH; PRIORITY JOURNAL; RESIDENTIAL AREA; SELF REPORT; TELEPHONE INTERVIEW; VACCINATION; WART VIRUS;

AUSTRALIA; HUMAN PAPILLOMAVIRUS (HPV); VACCINATION COVERAGE;

ADOLESCENT; ADULT; AUSTRALIA; FEMALE; HEALTH CARE SURVEYS; HUMANS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; VACCINATION; YOUNG ADULT;

EID: 84891661777     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.11.075     Document Type: Article

References (10)

1. Brotherton J.M.L. How much cervical cancer in Australia is vaccine preventable? A meta-analysis. Vaccine 2008, 26:250-256.
2. Ball S.L.R., Winder D.M., Vaughan K., Hanna N., Levy J., Sterling J.C., et al. Analyses of human papillomavirus genotypes and viral loads in anogenital warts. J Med Virol 2011, 83:1345-1350. 10.1002/jmv.22111.
3. Gertig D.M., Brotherton J.M.L., Saville M. Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia. Sex Health 2011, 8:171-178. 10.1071/SH10001.
4. Brotherton J., Gertig D., Chappell G., Rowlands L., Saville M. Catching up with the catch-up: HPV vaccination coverage data for Australian women aged 18-26 years from the National HPV Vaccination Program Register. Commun Dis Intell 2011, 35(2):197-201.
5. Liu B., Brotherton J.M.L., Shellard D., Donovan B., Saville M., Kaldor J.M. Mobile phones are a viable option for surveying young Australian women: a comparison of two telephone survey methods. BMC Med Res Methodol 2011, 11:159. 10.1186/1471-2288-11-159.
6. Brotherton J.M., Mullins R.M. Will vaccinated women attend cervical screening? A population based survey of human papillomavirus vaccination and cervical screening among young women in Victoria, Australia. Cancer Epidemiol 2012, 36(June (3)):298-302. 10.1016/j.canep.2011.11.005.
7. Brotherton J.M., Gold M.S., Kemp A.S., McIntyre P.B., Burgess M.A., Campbell-Lloyd S. Anaphylaxis following quadrivalent human papillomavirus vaccination. CMAJ 2008, 179(6):525-533. New South Wales Health HPV Adverse Events Panel. 10.1503/cmaj.080916.
8. Voigt L.F., Schwartz S.M., Doody D.R., Lee S.C., Li C.I. Feasibility of including cellular telephone numbers in random digit dialing for epidemiologic case-control studies. Am J Epidemiol 2011, 173:118-126.
9. Brotherton J.M.L., Murray S.L., Hall M., Andrewartha L.K., Banks C.A., Meijer D., et al. Human papillomavirus vaccine coverage among female Australian adolescents: success of the school based approach. Med J Aust 2013, 199:614-617.
10. Brotherton J.M.L., Batchelor M., Winch K. Utility of reports and routine correspondence from the National HPV Vaccination Program Register. Med J Aust 2013, 199(7):463.